Y-Intercept (HK)’s Select Medical SEM Stock Holding History

Y-Intercept (HK)’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.15M	Sell	69,442 -53,563	-44%	-$883K	0.02%	991
2026 Q1	$2M	Buy	123,005 +17,335	+16%	+$271K	0.04%	711
2025 Q4	$1.57M	Sell	105,670 -48,731	-32%	-$689K	0.04%	743
2025 Q3	$1.98M	Buy	154,401 +67,526	+78%	+$900K	0.05%	609
2025 Q2	$1.32M	Buy	+86,875	New	+$1.36M	0.03%	797
2024 Q4	–	Sell	-17,493	Closed	-$329K	–	1607
2024 Q3	$329K	Sell	17,493 -24,393	-58%	-$467K	0.02%	973
2024 Q2	$791K	Sell	41,886 -22,591	-35%	-$385K	0.04%	599
2024 Q1	$1.05M	Sell	64,477 -18,648	-22%	-$273K	0.08%	366
2023 Q4	$1.05M	Buy	83,125 +41,324	+99%	+$521K	0.1%	300
2023 Q3	$569K	Buy	41,801 +2,149	+5%	+$33.2K	0.06%	518
2023 Q2	$681K	Buy	39,652 +21,237	+115%	+$329K	0.07%	436
2023 Q1	$256K	Buy	+18,415	New	+$271K	0.03%	845

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Y-Intercept (HK)'s SEM Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Select Medical (SEM) stake by 44% in Q2 2026, selling an estimated $883K and leaving 69,442 shares worth $1.15M. The position accounts for 0.02% of the portfolio, ranked #991.

Y-Intercept (HK) first reported a position in SEM in Q1 2023 and has held it in 12 quarters since. The position peaked at $2M in Q1 2026. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Y-Intercept (HK) held 69,442 shares of Select Medical worth $1.15M as of Q2 2026.
Y-Intercept (HK) sold 53,563 Select Medical shares in Q2 2026, an estimated $883K.
Select Medical made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #991 holding.
Y-Intercept (HK) first reported a position in Select Medical in Q1 2023 and has held it in 12 quarters since.
Y-Intercept (HK)'s Select Medical position peaked at $2M in Q1 2026.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.